Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Engineering Natural Heart Valves: Possibilities and Challenges Publisher Pubmed



Namiri M1, 2 ; Ashtiani MK1 ; Mashinchian O1, 7 ; Hasanisadrabadi MM1, 3 ; Mahmoudi M4, 5, 6 ; Aghdami N1 ; Baharvand H1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Stem Cells and Developmental Biology, Cell Science Research Centre, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  2. 2. Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran
  3. 3. Department of Bioengineering, Georgia Institute of Technology, Atlanta, GA, United States
  4. 4. Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, CA, United States
  5. 5. Department of Nanotechnology and Nanotechnology Research Centre, Tehran University of Medical Sciences, Iran
  6. 6. Cardiovascular Institute, Stanford University School of Medicine, CA, United States
  7. 7. Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland

Source: Journal of Tissue Engineering and Regenerative Medicine Published:2017


Abstract

Heart valve replacement is considered to be the most prevalent treatment approach for cardiac valve-related diseases. Among current solutions for heart valve replacement, e.g. mechanical and bioprosthetic valves, the main shortcoming is the lack of growth capability, repair and remodelling of the substitute valve. During the past three decades, tissue engineering-based approaches have shown tremendous potential to overcome these limitations by the development of a biodegradable scaffold, which provides biomechanical and biochemical properties of the native tissue. Among various scaffolds employed for tissue engineering, the decellularized heart valve (DHV) has attracted much attention, due to its native structure as well as comparable haemodynamic characteristics. Although the human DHV has shown optimal properties for valve replacement, the limitation of valve donors in terms of time and size is their main clinical issue. In this regard, xenogenic DHV can be a promising candidate for heart valve replacement. Xenogenic DHVs have similar composition to human valves, which will overcome the need for human DHVs. The main concern regarding xenogeneic DHV replacement is the immunological reaction and calcification following implantation, weak mechanical properties and insufficient recellularization capacity. In this review, we describe the essential steps required to address these impediments through novel engineering approaches. Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.
Other Related Docs
10. Decellularizing Bone Tissue: Various Protocols, Regenerative Engineering and Translational Medicine (2024)
12. Growth Factor Conjugation: Strategies and Applications, Journal of Biomedical Materials Research - Part A (2015)
18. Pre-Vascularization Approaches for Heart Tissue Engineering, Regenerative Engineering and Translational Medicine (2021)
26. Fetal Lung Tissue Engineering, Advances in Experimental Medicine and Biology (2021)